| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.101.20.2382 |
| P698 | PubMed publication ID | 10821814 |
| P2093 | author name string | Haller H | |
| Luft FC | |||
| Mackman N | |||
| Park JK | |||
| Gulba DC | |||
| Dechend R | |||
| Theuer J | |||
| Kreuzer J | |||
| Wallukat G | |||
| Homuth V | |||
| Juepner A | |||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2382-2387 | |
| P577 | publication date | 2000-05-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | |
| P478 | volume | 101 |
| Q28069689 | A Dormant Microbial Component in the Development of Preeclampsia |
| Q53700889 | AT1-AA (Angiotensin II Type 1 Receptor Agonistic Autoantibody) Blockade Prevents Preeclamptic Symptoms in Placental Ischemic Rats. |
| Q37132801 | AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia |
| Q37507162 | Administration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy |
| Q34541831 | Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor Enhance Angiotensin II-Induced Renal Vascular Sensitivity and Reduce Renal Function During Pregnancy |
| Q34978758 | Agonistic antibody to angiotensin II type 1 receptor accelerates atherosclerosis in ApoE-/- mice |
| Q43291018 | Agonistic antibody to the alpha1-adrenergic receptor mobilizes intracellular calcium and induces phosphorylation of a cardiac 15-kDa protein |
| Q38207936 | Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases |
| Q36355165 | Agonistic autoantibodies to the angiotensin II type I receptor cause pathophysiologic characteristics of preeclampsia |
| Q36339336 | An increased population of regulatory T cells improves the pathophysiology of placental ischemia in a rat model of preeclampsia |
| Q24800784 | Angiotensin II induced inflammation in the kidney and in the heart of double transgenic rats |
| Q35699115 | Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy |
| Q35576417 | Angiotensin II type 1 autoantibody induced hypertension during pregnancy is associated with renal endothelial dysfunction |
| Q37353499 | Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension |
| Q64111458 | Angiotensin II type i receptor agonistic autoantibodies induces apoptosis of cardiomyocytes by downregulating miR21 in preeclampsia: a mechanism study |
| Q27027039 | Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond |
| Q35701236 | Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice |
| Q33748680 | Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity |
| Q34040304 | Angiotensin receptor agonistic autoantibody-mediated soluble fms-like tyrosine kinase-1 induction contributes to impaired adrenal vasculature and decreased aldosterone production in preeclampsia |
| Q33748650 | Angiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsia |
| Q33765684 | Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients |
| Q24605647 | Angiotensin receptors, autoimmunity, and preeclampsia |
| Q28534198 | Antibodies against AT1 receptors are associated with vascular endothelial and smooth muscle function impairment: protective effects of hydroxysafflor yellow A |
| Q34618522 | Association between the presence of autoantibodies against adrenoreceptors and severe pre-eclampsia: a pilot study |
| Q37348150 | Association of autoantibodies against the M2-muscarinic receptor with perinatal outcomes in women with severe preeclampsia |
| Q90599535 | Autoantibodies against AT1 Receptor Contribute to Vascular Aging and Endothelial Cell Senescence |
| Q42652420 | Autoantibodies targeting AT1 receptor from patients with acute coronary syndrome upregulate proinflammatory cytokines expression in endothelial cells involving NF-κB pathway |
| Q35681804 | Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling |
| Q35715914 | Autoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia |
| Q36050771 | Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling |
| Q34040357 | Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia |
| Q33789436 | B cells: the old new players in reproductive immunology |
| Q33799413 | Circulating and Vascular Bioactive Factors during Hypertension in Pregnancy |
| Q38220404 | Constitutive activity in the angiotensin II type 1 receptor: discovery and applications |
| Q54373900 | Correlation between HLA-DRB1, HLA-DQB1 polymorphism and autoantibodies against angiotensin AT(1) receptors in Chinese patients with essential hypertension. |
| Q34707028 | Elevated Plasma Chymotrypsin-like Protease (Chymase) Activity in Women with Preeclampsia |
| Q36836373 | Elevated Transglutaminase Activity Triggers Angiotensin Receptor Activating Autoantibody Production and Pathophysiology of Preeclampsia |
| Q33577570 | Endothelial dysfunction induced by antibodies against angiotensin AT1 receptor in immunized rats |
| Q48138762 | Expression of NADPH oxidase and production of reactive oxygen species in aorta in an active immunization mouse model with AT1-EC2 peptide |
| Q36584523 | HLA and MICA: targets of antibody-mediated rejection in heart transplantation. |
| Q46340735 | Heparin-mediated extracorporeal low density lipoprotein precipitation as a possible therapeutic approach in preeclampsia |
| Q83799951 | Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension |
| Q37447371 | Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. |
| Q35029700 | Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes |
| Q36997267 | IL-10 supplementation increases Tregs and decreases hypertension in the RUPP rat model of preeclampsia |
| Q36178540 | IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy |
| Q40774313 | Identification and characterization of functional angiotensin II type 1 receptors on immortalized human fetal aortic vascular smooth muscle cells |
| Q37139722 | Identifying immune mechanisms mediating the hypertension during preeclampsia |
| Q36241932 | International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected]. |
| Q36050775 | Is preeclampsia an autoimmune disease? |
| Q90106114 | Letter to the Editor: Importance of B cells in response to placental ischemia |
| Q35053657 | Maternal treatment with agonistic autoantibodies against type-1 angiotensin II receptor in late pregnancy increases apoptosis of myocardial cells and myocardial susceptibility to ischemia-reperfusion injury in offspring rats |
| Q36577103 | Mechanisms of disease: Pre-eclampsia |
| Q33344105 | Molecular mechanisms of preeclampsia |
| Q38017497 | Pathogenesis of pre-eclampsia: marinobufagenin and angiogenic imbalance as biomarkers of the syndrome |
| Q47548339 | Plasma Cell Depletion Attenuates Hypertension in an Experimental Model of Autoimmune Disease |
| Q35681821 | Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia |
| Q35911954 | Pre-eclampsia: is it all in the placenta? |
| Q26800272 | Preeclampsia: long-term consequences for vascular health |
| Q38691672 | Proliferation of endogenous regulatory T cells improve the pathophysiology associated with placental ischaemia of pregnancy |
| Q36537709 | RAS in Pregnancy and Preeclampsia and Eclampsia |
| Q35707881 | Receptor-activating autoantibodies and disease: preeclampsia and beyond |
| Q45848306 | Reduced uterine perfusion pressure T-helper 17 cells cause pathophysiology associated with preeclampsia during pregnancy |
| Q88493279 | Regulators of G protein signaling in cardiovascular function during pregnancy |
| Q92071252 | Renal natural killer cell activation and mitochondrial oxidative stress; new mechanisms in AT1-AA mediated hypertensive pregnancy |
| Q35743816 | Renin angiotensin signaling in normal pregnancy and preeclampsia |
| Q33793455 | Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy |
| Q46865405 | Role of the renin angiotensin system in TNF-alpha and Shiga-toxin-induced tissue factor expression |
| Q36776897 | Short-term outcome of patients with preeclampsia |
| Q44282332 | Spontaneously beating neonatal rat heart myocyte culture-a model to characterize angiotensin II at(1) receptor autoantibodies in patients with preeclampsia |
| Q37218199 | Systemic and uteroplacental renin--angiotensin system in normal and pre-eclamptic pregnancies |
| Q37206448 | The Prognostic Role of Angiotensin II Type 1 Receptor Autoantibody in Non-Gravid Hypertension and Pre-eclampsia: A Meta-analysis and Our Studies |
| Q37039872 | The functional role of the renin-angiotensin system in pregnancy and preeclampsia |
| Q46238640 | The immunology of hypertension. |
| Q34060768 | The multiple actions of angiotensin II in atherosclerosis |
| Q52972348 | The preeclampsia enigma and the renin-angiotensin system. |
| Q57150158 | The role of Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor (AT1-AA) in Pathophysiology of Preeclampsia |
| Q36467563 | The role of RAS in the pathogenesis of preeclampsia |
| Q33737470 | Tissue transglutaminase contributes to the pathogenesis of preeclampsia and stabilizes placental angiotensin receptor type 1 by ubiquitination-preventing isopeptide modification |
| Q33781354 | Vascular and cellular calcium in normal and hypertensive pregnancy |
| Q34577349 | Vasoreactivity of chorionic plate arteries in response to vasoconstrictors produced by preeclamptic placentas |
| Q33699863 | Vitamin D prevents endothelial progenitor cell dysfunction induced by sera from women with preeclampsia or conditioned media from hypoxic placenta |
| Q36699839 | Vitamin D supplementation improves pathophysiology in a rat model of preeclampsia |
Search more.